Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Blocking Wnt5a signaling decreases CD36 expression and foam cell formation in atherosclerosis.

Ackers I, Szymanski C, Duckett KJ, Consitt LA, Silver MJ, Malgor R.

Cardiovasc Pathol. 2018 May - Jun;34:1-8. doi: 10.1016/j.carpath.2018.01.008. Epub 2018 Feb 21.

PMID:
29474941
2.

Epigenetic supersimilarity of monozygotic twin pairs.

Van Baak TE, Coarfa C, Dugué PA, Fiorito G, Laritsky E, Baker MS, Kessler NJ, Dong J, Duryea JD, Silver MJ, Saffari A, Prentice AM, Moore SE, Ghantous A, Routledge MN, Gong YY, Herceg Z, Vineis P, Severi G, Hopper JL, Southey MC, Giles GG, Milne RL, Waterland RA.

Genome Biol. 2018 Jan 9;19(1):2. doi: 10.1186/s13059-017-1374-0.

3.

Estimation of a significance threshold for epigenome-wide association studies.

Saffari A, Silver MJ, Zavattari P, Moi L, Columbano A, Meaburn EL, Dudbridge F.

Genet Epidemiol. 2018 Feb;42(1):20-33. doi: 10.1002/gepi.22086. Epub 2017 Oct 15.

4.

Influence of intergenerational in utero parental energy and nutrient restriction on offspring growth in rural Gambia.

Eriksen KG, Radford EJ, Silver MJ, Fulford AJC, Wegmüller R, Prentice AM.

FASEB J. 2017 Nov;31(11):4928-4934. doi: 10.1096/fj.201700017R. Epub 2017 Aug 4.

5.

Popliteal artery entrapment syndrome presenting as Raynaud phenomenon.

Passias B, Lyden S, Frederick A, Jolly M, Silver MJ.

Vasc Med. 2017 Oct;22(5):435-436. doi: 10.1177/1358863X17714065. Epub 2017 Jun 20. No abstract available.

PMID:
28633610
6.

Analysis of the Final DENALI Trial Data: A Prospective, Multicenter Study of the Denali Inferior Vena Cava Filter.

Stavropoulos SW, Chen JX, Sing RF, Elmasri F, Silver MJ, Powell A, Lynch FC, Abdel Aal AK, Lansky A, Muhs BE; DENALI Trial Investigators.

J Vasc Interv Radiol. 2016 Oct;27(10):1531-1538.e1. doi: 10.1016/j.jvir.2016.06.028. Epub 2016 Aug 26.

7.

Authors' Response to Wong et al.

Silver AJ, Silver MJ, Lim RM, Borroto C, Morriss A, Silver LM.

Genet Test Mol Biomarkers. 2016 Aug;20(8):414-5. doi: 10.1089/gtmb.2016.29020.ajs. No abstract available.

PMID:
27505439
8.

Carrier Screening is a Deficient Strategy for Determining Sperm Donor Eligibility and Reducing Risk of Disease in Recipient Children.

Silver AJ, Larson JL, Silver MJ, Lim RM, Borroto C, Spurrier B, Morriss A, Silver LM.

Genet Test Mol Biomarkers. 2016 Jun;20(6):276-84. doi: 10.1089/gtmb.2016.0014. Epub 2016 Apr 22.

9.

Response to Sosnay et al.

Larson JL, Lim RM, Silver AJ, Silver MJ, Borroto C, Spurrier B, Petrossian TC, Silver LM.

Genet Med. 2016 Feb;18(2):209-10. doi: 10.1038/gim.2015.106. Epub 2015 Oct 29. No abstract available.

PMID:
26513348
10.

Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environment.

Silver MJ, Kessler NJ, Hennig BJ, Dominguez-Salas P, Laritsky E, Baker MS, Coarfa C, Hernandez-Vargas H, Castelino JM, Routledge MN, Gong YY, Herceg Z, Lee YS, Lee K, Moore SE, Fulford AJ, Prentice AM, Waterland RA.

Genome Biol. 2015 Jun 11;16:118. doi: 10.1186/s13059-015-0660-y.

11.

Evidence for negative selection of gene variants that increase dependence on dietary choline in a Gambian cohort.

Silver MJ, Corbin KD, Hellenthal G, da Costa KA, Dominguez-Salas P, Moore SE, Owen J, Prentice AM, Hennig BJ, Zeisel SH.

FASEB J. 2015 Aug;29(8):3426-35. doi: 10.1096/fj.15-271056. Epub 2015 Apr 28.

12.

Targeted mutation screening panels expose systematic population bias in detection of cystic fibrosis risk.

Lim RM, Silver AJ, Silver MJ, Borroto C, Spurrier B, Petrossian TC, Larson JL, Silver LM.

Genet Med. 2016 Feb;18(2):174-9. doi: 10.1038/gim.2015.52. Epub 2015 Apr 16.

PMID:
25880441
13.

Exposure to aflatoxin B1 in utero is associated with DNA methylation in white blood cells of infants in The Gambia.

Hernandez-Vargas H, Castelino J, Silver MJ, Dominguez-Salas P, Cros MP, Durand G, Le Calvez-Kelm F, Prentice AM, Wild CP, Moore SE, Hennig BJ, Herceg Z, Gong YY, Routledge MN.

Int J Epidemiol. 2015 Aug;44(4):1238-48. doi: 10.1093/ije/dyv027. Epub 2015 Apr 7.

14.

The DENALI Trial: an interim analysis of a prospective, multicenter study of the Denali retrievable inferior vena cava filter.

Stavropoulos SW, Sing RF, Elmasri F, Silver MJ, Powell A, Lynch FC, Aal AK, Lansky AJ, Settlage RA, Muhs BE; DENALI Trial Investigators.

J Vasc Interv Radiol. 2014 Oct;25(10):1497-505, 1505.e1. doi: 10.1016/j.jvir.2014.07.001. Epub 2014 Jul 25.

15.

The role of renal denervation in the treatment of hypertension.

Feldmann KJ, Silver MJ.

Curr Treat Options Cardiovasc Med. 2014 Jul;16(7):321. doi: 10.1007/s11936-014-0321-6.

PMID:
24872084
16.

Maternal nutrition at conception modulates DNA methylation of human metastable epialleles.

Dominguez-Salas P, Moore SE, Baker MS, Bergen AW, Cox SE, Dyer RA, Fulford AJ, Guan Y, Laritsky E, Silver MJ, Swan GE, Zeisel SH, Innis SM, Waterland RA, Prentice AM, Hennig BJ.

Nat Commun. 2014 Apr 29;5:3746. doi: 10.1038/ncomms4746.

17.

Wnt5a, TLR2 and TLR4 are elevated in advanced human atherosclerotic lesions.

Malgor R, Bhatt PM, Connolly BA, Jacoby DL, Feldmann KJ, Silver MJ, Nakazawa M, McCall KD, Goetz DJ.

Inflamm Res. 2014 Apr;63(4):277-85. doi: 10.1007/s00011-013-0697-x. Epub 2013 Dec 18.

18.

Increased Wnt5a mRNA Expression in Advanced Atherosclerotic Lesions, and Oxidized LDL Treated Human Monocyte-Derived Macrophages.

Bhatt PM, Lewis CJ, House DL, Keller CM, Kohn LD, Silver MJ, McCall KD, Goetz DJ, Malgor R.

Open Circ Vasc J. 2012;5:1-7.

19.

Common types of supraventricular tachycardia: diagnosis and management.

Colucci RA, Silver MJ, Shubrook J.

Am Fam Physician. 2010 Oct 15;82(8):942-52. Review.

20.

Emergency department use by older adults: a literature review on trends, appropriateness, and consequences of unmet health care needs.

Gruneir A, Silver MJ, Rochon PA.

Med Care Res Rev. 2011 Apr;68(2):131-55. doi: 10.1177/1077558710379422. Epub 2010 Sep 9. Review.

PMID:
20829235
21.
22.

Wnt5a is expressed in murine and human atherosclerotic lesions.

Christman MA 2nd, Goetz DJ, Dickerson E, McCall KD, Lewis CJ, Benencia F, Silver MJ, Kohn LD, Malgor R.

Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2864-70. doi: 10.1152/ajpheart.00982.2007. Epub 2008 May 2.

23.

The use of femoropopliteal stent-grafts for critical limb ischemia.

Ansel GM, Botti CF Jr, Silver MJ.

Tech Vasc Interv Radiol. 2005 Dec;8(4):140-5. Review.

PMID:
16849092
24.

Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: a randomized trial.

Ansel GM, Silver MJ, Botti CF Jr, Rocha-Singh K, Bates MC, Rosenfield K, Schainfeld RM, Laster SB, Zander C.

Catheter Cardiovasc Interv. 2006 Feb;67(2):288-97.

PMID:
16408299
25.

Mechanical thrombectomy in peripheral arterial interventions.

Ansel GM, Botti CF Jr, Silver MJ.

J Invasive Cardiol. 2004 May;16(5 Suppl):10S-14S; quiz 14S-15S. Review.

PMID:
23573626
26.

Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia.

Ansel GM, Sample NS, Botti III CF Jr, Tracy AJ, Silver MJ, Marshall BJ, George BS.

Catheter Cardiovasc Interv. 2004 Jan;61(1):1-4.

PMID:
14696150
27.

Percutaneous retrograde tibial access in limb salvage.

Botti CF Jr, Ansel GM, Silver MJ, Barker BJ, South S.

J Endovasc Ther. 2003 Jun;10(3):614-8.

PMID:
12932176
28.

The role of radiation therapy in the treatment of femoropopliteal occlusive disease.

Chellini J, Ansel GM, Botti CF Jr, Silver MJ.

J Invasive Cardiol. 2003 Jan;15 Suppl A:21A-24A. Review.

PMID:
12668838
29.

Use of glycoprotein IIb/IIIa platelet inhibitors in peripheral vascular interventions.

Ansel GM, George BS, Botti CF, Silver MJ.

Rev Cardiovasc Med. 2002;3 Suppl 1:S35-40. Review.

PMID:
12439435
30.

Femoropopliteal occlusive disease: diagnosis, indications for treatment, and results of interventional therapy.

Silver MJ, Ansel GM.

Catheter Cardiovasc Interv. 2002 Aug;56(4):555-61. Review.

PMID:
12124973
31.

Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy.

Kapadia SR, Bajzer CT, Ziada KM, Bhatt DL, Wazni OM, Silver MJ, Beven EG, Ouriel K, Yadav JS.

Stroke. 2001 Oct;32(10):2328-32.

32.

Infrapopliteal Endovascular Techniques: Indications, Techniques, and Results.

Ansel GM, George BS, Botti CF Jr, Silver MJ.

Curr Interv Cardiol Rep. 2001 May;3(2):100-108.

PMID:
11322913
33.

Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade.

Cura FA, Kapadia SR, L'Allier PL, Schneider JP, Kreindel MS, Silver MJ, Yadav JS, Simpfendorfer CC, Raymond RR, Tuzcu EM, Franco I, Whitlow PL, Topol EJ, Ellis SG.

Am J Cardiol. 2000 Oct 1;86(7):780-2, A9.

PMID:
11018201
34.

Intermediate outcome after carotid stenting: what should we expect?

Silver MJ, Yadav JS, Wholey M.

Semin Vasc Surg. 2000 Jun;13(2):130-8. Review.

PMID:
10879553
35.

Influence of a randomized clinical trial on practice by participating investigators: lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). CAVEAT I and II Investigators.

Omoigui NA, Silver MJ, Rybicki LA, Rosenthal M, Berdan LG, Pieper K, King SV, Califf RM, Topol EJ.

J Am Coll Cardiol. 1998 Feb;31(2):265-72.

36.

Amiodarone in congestive heart failure.

Silver MJ, Young J, Topol EJ.

N Engl J Med. 1995 Dec 14;333(24):1639-40; author reply 1640-1. No abstract available.

37.

Adjunctive selectin blockade successfully reduces infarct size beyond thrombolysis in the electrolytic canine coronary artery model.

Silver MJ, Sutton JM, Hook S, Lee P, Malycky JL, Phillips ML, Ellis SG, Topol EJ, Nicolini FA.

Circulation. 1995 Aug 1;92(3):492-9.

38.

Reduction of blood loss from diagnostic sampling in critically ill patients using a blood-conserving arterial line system.

Silver MJ, Li YH, Gragg LA, Jubran F, Stoller JK.

Chest. 1993 Dec;104(6):1711-5.

PMID:
8252948
39.

Acute noncardiogenic pulmonary edema due to polymer fume fever.

Silver MJ, Young DK.

Cleve Clin J Med. 1993 Nov-Dec;60(6):479-82.

PMID:
8287510
40.

Evaluation of a new blood-conserving arterial line system for patients in intensive care units.

Silver MJ, Jubran H, Stein S, McSweeney T, Jubran F.

Crit Care Med. 1993 Apr;21(4):507-11.

PMID:
8472568
41.

A role for platelets and thrombin in the juvenile stroke of two siblings with defective thrombin-adsorbing capacity of fibrin(ogen).

Di Minno G, Martinez J, Cirillo F, Cerbone AM, Silver MJ, Colucci M, Margaglione M, Tauro R, Semeraro N, Quattrone A, et al.

Arterioscler Thromb. 1991 Jul-Aug;11(4):785-96.

42.

Eicosapentaenoic acid ethyl ester as an antithrombotic agent: comparison to an extract of fish oil.

Wojenski CM, Silver MJ, Walker J.

Biochim Biophys Acta. 1991 Jan 4;1081(1):33-8.

PMID:
1991153
43.

Aspirin as an antithrombotic agent.

Silver MJ, Di Minno G.

Prog Drug Res. 1989;33:43-62. Review. No abstract available.

PMID:
2687944
44.

Prostacyclin synthesis by endothelial cells from human umbilical veins: effect of cumulative population doublings.

Ingerman-Wojenski CM, Silver MJ, Mueller SN, Levine EM.

Prostaglandins. 1988 Aug;36(2):127-37.

PMID:
3141975
46.

The carbon dioxide rate of rise in awake apneic humans.

Stock MC, Downs JB, McDonald JS, Silver MJ, McSweeney TD, Fairley DS.

J Clin Anesth. 1988;1(2):96-103.

PMID:
3152423
47.
48.
49.

Acetyltransferase activity in human platelet microsomes and washed platelets.

Alam I, Silver MJ.

Biochim Biophys Acta. 1986 Oct 29;884(1):67-72.

PMID:
3094588
50.

Trial of repeated low-dose aspirin in diabetic angiopathy.

DiMinno G, Silver MJ, Cerbone AM, Murphy S.

Blood. 1986 Oct;68(4):886-91.

Supplemental Content

Loading ...
Support Center